Predictive Significance of Interleukins 17A and 33 in Risk of Relapsing–Remitting Multiple Sclerosis. Baghdad Sci.J [Internet]. 2022 Dec. 1 [cited 2025 Jan. 22];19(6):1191. Available from: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/6431